These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9680143)

  • 1. An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus.
    Vanlandschoot P; Beirnaert E; Barrère B; Calder L; Millar B; Wharton S; Jou WM; Fiers W
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1781-91. PubMed ID: 9680143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
    Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
    Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of fusion activity of influenza A haemagglutinin mediated by HA2-specific monoclonal antibodies.
    Varecková E; Mucha V; Wharton SA; Kostolanský F
    Arch Virol; 2003 Mar; 148(3):469-86. PubMed ID: 12607099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus.
    Varecková E; Wharton SA; Mucha V; Gocník M; Kostolanský F
    Acta Virol; 2003; 47(4):229-36. PubMed ID: 15068378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.
    Skehel JJ; Wiley DC
    Annu Rev Biochem; 2000; 69():531-69. PubMed ID: 10966468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to the haemagglutinin HA1 subunit of the pandemic influenza A/H1N1 2009 virus and potential application to serodiagnosis.
    Samuel D; Warrener L; Hoschler K
    J Med Virol; 2011 Apr; 83(4):559-67. PubMed ID: 21328368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in response among individuals to antigenic sites on the HA protein of human influenza virus may be responsible for the emergence of drift strains in the human population.
    Nakajima S; Nobusawa E; Nakajima K
    Virology; 2000 Aug; 274(1):220-31. PubMed ID: 10936103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses.
    Wang W; Sun X; Li Y; Su J; Ling Z; Zhang T; Wang F; Zhang H; Chen H; Ding J; Sun B
    Nat Commun; 2016 Dec; 7():13577. PubMed ID: 27910950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity.
    Edwards MJ; Dimmock NJ
    J Gen Virol; 2001 Jun; 82(Pt 6):1387-1395. PubMed ID: 11369883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fairly conserved epitope on the hemagglutinin of influenza A (H3N2) virus with variable accessibility to neutralizing antibody.
    Vanlandschoot P; Beirnaert E; Dewilde S; Saelens X; Bestebroer T; De Jong J; Jou WM; Fiers W
    Virology; 1995 Oct; 212(2):526-34. PubMed ID: 7571422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes.
    Varecková E; Mucha V; Kostolanský F; Gubareva LV; Klimov A
    Virus Res; 2008 Mar; 132(1-2):181-6. PubMed ID: 18037184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-induced conformational changes of membrane-bound influenza hemagglutinin and its effect on target lipid bilayers.
    Gray C; Tamm LK
    Protein Sci; 1998 Nov; 7(11):2359-73. PubMed ID: 9828002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intersubunit region of the influenza virus haemagglutinin is recognized by antibodies during infection.
    Nagy Z; Rajnavölgyi E; Hollósi M; Tóth GK; Váradi G; Penke B; Tóth I; Horváth A; Gergely J; Kurucz I
    Scand J Immunol; 1994 Sep; 40(3):281-91. PubMed ID: 8091127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between original strains and their mouse-adapted variants of human (H1) and avian (H2) influenza A viruses in the reaction with cross-neutralizing monoclonal antibody recognizing conformational epitope.
    Lipatov AS; Gitelman AK; Smirnov YuA
    Acta Virol; 1996 Sep; 40(4):227-30. PubMed ID: 9014015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristic features of InfA-15 monoclonal antibody recognizing H1, H3, and H5 subtypes of hemagglutinin of influenza virus A type.
    Hifumi E; Fujimoto N; Ishida K; Kawawaki H; Uda T
    J Biosci Bioeng; 2010 Jun; 109(6):598-608. PubMed ID: 20471600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.
    Edwards MJ; Dimmock NJ
    J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colocalization of intracellular specific IgA (icIgA) with influenza virus in patients' nasopharyngeal aspirate cells.
    Kok TW; Costabile M; Tannock GA; Li P
    J Virol Methods; 2018 Feb; 252():8-14. PubMed ID: 29102516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion of influenza virus with the endosomal membrane is inhibited by monoclonal antibodies to defined epitopes on the hemagglutinin.
    Imai M; Sugimoto K; Okazaki K; Kida H
    Virus Res; 1998 Feb; 53(2):129-39. PubMed ID: 9620205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into structural diversity of influenza virus haemagglutinin.
    Cho KJ; Lee JH; Hong KW; Kim SH; Park Y; Lee JY; Kang S; Kim S; Yang JH; Kim EK; Seok JH; Unzai S; Park SY; Saelens X; Kim CJ; Lee JY; Kang C; Oh HB; Chung MS; Kim KH
    J Gen Virol; 2013 Aug; 94(Pt 8):1712-1722. PubMed ID: 23636824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological properties of H5 hemagglutinin expressed by vaccinia virus vector and its immunological reactivity with human sera.
    Noisumdaeng P; Pooruk P; Kongchanagul A; Assanasen S; Kitphati R; Auewarakul P; Puthavathana P
    Viral Immunol; 2013 Feb; 26(1):49-59. PubMed ID: 23374152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.